Charles River Labs cuts expansion plans by $140M
The change is a result of “unforeseen regulator and economic uncertainties associated with the specialized health manufacturing industry,” according to documents.
There are 2 article(s) tagged Cognate BioServices:
The change is a result of “unforeseen regulator and economic uncertainties associated with the specialized health manufacturing industry,” according to documents.
The bio-services firm commits to creating 561 more jobs that pay $63,749 on average, and to making a $212.9 million capital investment.
About 2 results